Form 8-K - Current report:
SEC Accession No. 0001628280-24-028287
Filing Date
2024-06-14
Accepted
2024-06-14 16:07:16
Documents
14
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K dna-20240613.htm   iXBRL 8-K 48148
  Complete submission text file 0001628280-24-028287.txt   217037

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20240613.xsd EX-101.SCH 2315
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20240613_def.xml EX-101.DEF 15988
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20240613_lab.xml EX-101.LAB 28325
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20240613_pre.xml EX-101.PRE 16726
17 EXTRACTED XBRL INSTANCE DOCUMENT dna-20240613_htm.xml XML 4173
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 241044770
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)